Cellares Raises $257 Million Series D Led by BlackRock and Eclipse to Industrialize Global Cell Therapy Manufacturing.
Amount Raised
$257 Million
Round Type
Series D
South San FranciscoManufacturingBiotechnologyInvestors
Description
Cellares announced a $257 million Series D financing co-led by BlackRock and Eclipse, bringing the total capital raised to $612 million. The funds will support the buildout of automated IDMO Smart Factories in multiple locations. Cellares aims to revolutionize cell therapy manufacturing with high-tech automation. The investment will help meet the rising demand for cell therapies globally.
Quick answer
Cellares raised $257 Million in a Series D round, dated January 28, 2026. Investors: T. Rowe Price Investment Management, Inc., Baillie Gifford, DFJ Growth, Willett Advisors, Eclipse, Edbi, Gates Frontier and Intuitive Ventures. Cellares is based in South San Francisco, California, United States.
- How much did Cellares raise?
- Cellares raised $257 Million in a Series D round on January 28, 2026.
- Who invested in Cellares?
- T. Rowe Price Investment Management, Inc., Baillie Gifford, DFJ Growth, Willett Advisors, Eclipse, Edbi, Gates Frontier and Intuitive Ventures are named as investors in this round.
- What does Cellares do?
- Cellares is the first Integrated Development and Manufacturing Organization (IDMO) and takes an Industry 4.0 approach to mass manufacturing the living drugs of the 21st century.
- Where is Cellares based and how big is it?
- Cellares is based in South San Francisco, California, United States. Fundz records about 300 employees.
- Who are the decision-makers at Cellares?
- Fundz holds 1 contact at Cellares, including the Co-Founder & CEO. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Manufacturing and Biotechnology around the same time
Companies in the same sectors as Cellares that raised within 45 days of this round, from Fundz verified event records.
- Monteris Medical raised $28M (Series E) on March 12, 2026.
- XCath raised $30M (Series C) on March 12, 2026.
- Electra Therapeutics raised $30M (Debt Financing) on March 11, 2026.
- Tenon Medical raised $4.3M on March 11, 2026.
- Advanced Machine Intelligence raised $1B (Funding Round) on March 10, 2026.
- Seprify raised $16M (Series A) on March 10, 2026.
Who to call at Cellares, and when
A new round usually means Cellares is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Cellares raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Cellares, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Cellares. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Cellares raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Cellares raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.